Cite
HARVARD Citation
Nair, N. et al. (2015). Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer. Journal for immunotherapy of cancer. 3 (2), pp. 1-2. [Online].